Cargando…
Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
This review aimed to summarize the evidence of elevated remnant cholesterol and the risks of atherosclerotic cardiovascular disease (ASCVD) and to search for further guidance in clinical therapy. The lipids-lowering treatments such as statins and ezetimibe targeted on low-density lipoprotein cholest...
Autores principales: | Wang, Kexin, Wang, Rui, Yang, Jiaxin, Liu, Xiaoli, Shen, Hua, Sun, Yan, Zhou, Yujie, Fang, Zhe, Ge, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621322/ https://www.ncbi.nlm.nih.gov/pubmed/36324753 http://dx.doi.org/10.3389/fcvm.2022.913869 |
Ejemplares similares
-
Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study
por: Kexin, Wang, et al.
Publicado: (2021) -
Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022) -
The Association Between Remnant Cholesterol and the Estimated 10-Year Risk of a First Hard Cardiovascular Event
por: Yang, Zhen, et al.
Publicado: (2022) -
Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022) -
Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults
por: Zhou, Liyuan, et al.
Publicado: (2022)